Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6531)
All Articles published online
|
Publishing Process of This Article
|
Apr 14, 2021 (publication date) through Apr 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Luo X, Luo SZ, Xu ZX, Zhou C, Li ZH, Zhou XY, Xu MY. Lipotoxic hepatocyte-derived exosomal miR-1297 promotes hepatic stellate cell activation through the PTEN signaling pathway in metabolic-associated fatty liver disease. World J Gastroenterol 2021; 27(14): 1419-1434 [PMID: 33911465 DOI: 10.3748/wjg.v27.i14.1419] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i14/1419.htm |
| Number | Citing Articles |
| 1 |
Andrea Barrientos-Riosalido, Monica Real, Laia Bertran, Carmen Aguilar, Salomé Martínez, David Parada, Margarita Vives, Fàtima Sabench, David Riesco, Daniel Del Castillo, Cristóbal Richart, Teresa Auguet. Increased Hepatic ATG7 mRNA and ATG7 Protein Expression in Nonalcoholic Steatohepatitis Associated with Obesity. International Journal of Molecular Sciences 2023; 24(2): 1324 doi: 10.3390/ijms24021324
|
| 2 |
Danna Xie, Baolin Qian, Xun Li. Nucleic acids and proteins carried by exosomes from various sources: Potential role in liver diseases. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.957036
|
| 3 |
Hong Li, Tingli Liu, Yongchun Yang, William C. Cho, Robin J. Flynn, Majid Fasihi Harandi, Houhui Song, Xuenong Luo, Yadong Zheng. Interplays of liver fibrosis-associated microRNAs: Molecular mechanisms and implications in diagnosis and therapy. Genes & Diseases 2023; 10(4): 1457 doi: 10.1016/j.gendis.2022.08.013
|
| 4 |
Ezhilarasan Devaraj, Elumalai Perumal, Raghunandhakumar Subramaniyan, Najimi Mustapha. Liver fibrosis: Extracellular vesicles mediated intercellular communication in perisinusoidal space. Hepatology 2022; 76(1): 275 doi: 10.1002/hep.32239
|
| 5 |
Xiang Liu, Jiazichao Tu, Ziqin Zhou, Bingxin Huang, Jianrong Zhou, Jimei Chen, Jianqin Wei. TMAO-Activated Hepatocyte-Derived Exosomes Are Widely Distributed in Mice with Different Patterns and Promote Vascular Inflammation. Cardiology Research and Practice 2022; 2022: 1 doi: 10.1155/2022/5166302
|
| 6 |
Yufei Liu, Yuhong Zheng, Yang Yang, Ke Liu, Jianying Wu, Peiyang Gao, Chuantao Zhang. Exosomes in liver fibrosis: The role of modulating hepatic stellate cells and immune cells, and prospects for clinical applications. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1133297
|
| 7 |
Samaneh Salehipour Bavarsad, Mohammad Taha Jalali, Darioush Bijan Nejad, Behnam Alypoor, Hossein Babaahmadi Rezaei, Narges Mohammadtaghvaei. TGFβ1-Pretreated Exosomes of Wharton Jelly Mesenchymal Stem Cell as a Therapeutic Strategy for Improving Liver Fibrosis. Hepatitis Monthly 2022; 22(1) doi: 10.5812/hepatmon-123416
|
| 8 |
Yu Zheng, Long Xie, Dejun Yang, Kaipei Luo, Xiaofang Li. Small-molecule natural plants for reversing liver fibrosis based on modulation of hepatic stellate cells activation: An update. Phytomedicine 2023; 113: 154721 doi: 10.1016/j.phymed.2023.154721
|
| 9 |
Liang'en Chen, Xiangshi Ye, Lixian Yang, Jiangsha Zhao, Jia You, Yuxiong Feng. Linking fatty liver diseases to hepatocellular carcinoma by hepatic stellate cells. Journal of the National Cancer Center 2024; 4(1): 25 doi: 10.1016/j.jncc.2024.01.002
|
| 10 |
Xiang Liu, Yijia Shao, Jiazichao Tu, Jiapan Sun, Bing Dong, Zhichao Wang, Jianrong Zhou, Long Chen, Jun Tao, Jimei Chen. TMAO-Activated Hepatocyte-Derived Exosomes Impair Angiogenesis via Repressing CXCR4. Frontiers in Cell and Developmental Biology 2022; 9 doi: 10.3389/fcell.2021.804049
|
| 11 |
Ali Mahmoudi, Alexandra E. Butler, Tannaz Jamialahmadi, Amirhossein Sahebkar. The role of exosomal miRNA in nonalcoholic fatty liver disease. Journal of Cellular Physiology 2022; 237(4): 2078 doi: 10.1002/jcp.30699
|
| 12 |
Tanghua Li, Jiapeng Jiao, Haoteng Ke, Wenshan Ouyang, Luobin Wang, Jin Pan, Xin Li. Role of exosomes in the development of the immune microenvironment in hepatocellular carcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1200201
|
| 13 |
Xingtao Zhao, Xinyan Xue, Zhifu Cui, Felix Kwame Amevor, Yan Wan, Ke Fu, Cheng Wang, Cheng Peng, Yunxia Li. microRNAs‐based diagnostic and therapeutic applications in liver fibrosis. WIREs RNA 2023; 14(4) doi: 10.1002/wrna.1773
|
| 14 |
Samar A. Zailaie, Basmah B. Khoja, Jumana J. Siddiqui, Mohammad H. Mawardi, Emily Heaphy, Amjad Aljagthmi, Consolato M. Sergi. Investigating the Role of Non-Coding RNA in Non-Alcoholic Fatty Liver Disease. Non-Coding RNA 2024; 10(1): 10 doi: 10.3390/ncrna10010010
|
| 15 |
Xiaona Zhao, Xinxin Kong, Zhoujun Cui, Zejin Zhang, Minghui Wang, Guoqing Liu, Honggang Gao, Jing Zhang, Wei Qin. Communication between nonalcoholic fatty liver disease and atherosclerosis: Focusing on exosomes. European Journal of Pharmaceutical Sciences 2024; 193: 106690 doi: 10.1016/j.ejps.2024.106690
|
| 16 |
Maria Teresa Koenen, Elisa Fabiana Brandt, Dawid Marcin Kaczor, Tim Caspers, Alexandra Catharina Anna Heinzmann, Petra Fischer, Daniel Heinrichs, Theresa Hildegard Wirtz, Christian Trautwein, Rory R Koenen, Marie-Luise Berres. Extracellular Vesicles from Steatotic Hepatocytes Provoke Pro-Fibrotic Responses in Cultured Stellate Cells. Biomolecules 2022; 12(5): 698 doi: 10.3390/biom12050698
|
| 17 |
Chanbin Lee, Jinsol Han, Youngmi Jung. Pathological Contribution of Extracellular Vesicles and Their MicroRNAs to Progression of Chronic Liver Disease. Biology 2022; 11(5): 637 doi: 10.3390/biology11050637
|
| 18 |
Jin-Mei Yao, Hua-Zhong Ying, Huan-Huan Zhang, Fen-Sheng Qiu, Jun-Qi Wu, Chen-Huan Yu. Exosomal RBP4 potentiated hepatic lipid accumulation and inflammation in high-fat-diet-fed mice by promoting M1 polarization of Kupffer cells. Free Radical Biology and Medicine 2023; 195: 58 doi: 10.1016/j.freeradbiomed.2022.12.085
|
| 19 |
Shahin Alizadeh-Fanalou, Mohsen Khosravi, Fatemeh Alian, Shirin Rokhsartalb-Azar, Ali Nazarizadeh, Maryam Karimi-Dehkordi, Forogh Mohammadi. Dual role of microRNA-1297 in the suppression and progression of human malignancies. Biomedicine & Pharmacotherapy 2021; 141: 111863 doi: 10.1016/j.biopha.2021.111863
|
| 20 |
Xiaojie Hu, Qinglin Ge, Yunting Zhang, Bowen Li, Erli Cheng, Yinghong Wang, Yan Huang. A review of the effect of exosomes from different cells on liver fibrosis. Biomedicine & Pharmacotherapy 2023; 161: 114415 doi: 10.1016/j.biopha.2023.114415
|
| 21 |
Youli Yao, Da Chen, Zengchang Yue. The regulatory role and mechanism of exosomes in hepatic fibrosis. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1284742
|
| 22 |
Le Li, Zhijun Zhu. Pharmacological modulation of ferroptosis as a therapeutic target for liver fibrosis. Frontiers in Pharmacology 2023; 13 doi: 10.3389/fphar.2022.1071844
|
| 23 |
Chun-Liang Chen, Yu-Cheng Lin. Autophagy Dysregulation in Metabolic Associated Fatty Liver Disease: A New Therapeutic Target. International Journal of Molecular Sciences 2022; 23(17): 10055 doi: 10.3390/ijms231710055
|
| 24 |
Qingfu Dong, Haolin Bao, Jiangang Wang, Wujiang Shi, Xinlei Zou, Jialin Sheng, Jianjun Gao, Canghai Guan, Haoming Xia, Jinglin Li, Pengcheng Kang, Yi Xu, Yunfu Cui, Xiangyu Zhong. Liver fibrosis and MAFLD: the exploration of multi-drug combination therapy strategies. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1120621
|
| 25 |
Xiaoyan Qi, Jinping Lai. Exosomal microRNAs and Progression of Nonalcoholic Steatohepatitis (NASH). International Journal of Molecular Sciences 2022; 23(21): 13501 doi: 10.3390/ijms232113501
|
| 26 |
Ji Sun, Dianbao Zhang, Yiling Li. Extracellular Vesicles in Pathogenesis and Treatment of Metabolic Associated Fatty Liver Disease. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.909518
|
| 27 |
Hongjian Lu, Ronghua Zhang, Shukun Zhang, Yufeng Li, Yankun Liu, Yanan Xiong, Xiaohan Yu, Tao Lan, Xin Li, Meimei Wang, Zhiyong Liu, Guangling Zhang, Jingwu Li, Shuang Chen. HSC-derived exosomal miR-199a-5p promotes HSC activation and hepatocyte EMT via targeting SIRT1 in hepatic fibrosis. International Immunopharmacology 2023; 124: 111002 doi: 10.1016/j.intimp.2023.111002
|
| 28 |
Qing-Yuan Li, Tao Gong, Yi-Ke Huang, Lan Kang, Charlotte A Warner, He Xie, Li-Min Chen, Xiao-Qiong Duan. Role of noncoding RNAs in liver fibrosis. World Journal of Gastroenterology 2023; 29(9): 1446-1459 doi: 10.3748/wjg.v29.i9.1446
|
| 29 |
Wei Jiang, Youhui Xu, Jou-Chen Chen, Yi-Hung Lee, Yushin Hu, Chang-Hai Liu, Enqiang Chen, Hong Tang, Hua Zhang, Dongbo Wu. Role of extracellular vesicles in nonalcoholic fatty liver disease. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1196831
|
| 30 |
Jing Li, Jingwen Fang, Xiaohong Jiang, Yujing Zhang, Antonio Vidal-Puig, Chen-Yu Zhang. RNAkines are secreted messengers shaping health and disease. Trends in Endocrinology & Metabolism 2024; 35(3): 201 doi: 10.1016/j.tem.2023.12.004
|
| 31 |
Zhiping Wan, Xiaoan Yang, Xiaoquan Liu, Yinfang Sun, Piaojian Yu, Fen Xu, Hong Deng. M2 macrophage-derived exosomal microRNA-411-5p impedes the activation of hepatic stellate cells by targeting CAMSAP1 in NASH model. iScience 2022; 25(7): 104597 doi: 10.1016/j.isci.2022.104597
|
| 32 |
Agata Wawrzkiewicz-Jałowiecka, Anna Lalik, Agnieszka Lukasiak, Monika Richter-Laskowska, Paulina Trybek, Maciej Ejfler, Maciej Opałka, Sonia Wardejn, Domenico V. Delfino. Potassium Channels, Glucose Metabolism and Glycosylation in Cancer Cells. International Journal of Molecular Sciences 2023; 24(9): 7942 doi: 10.3390/ijms24097942
|